(Q39354729)

11 September 2017

title

Effect of group-A meningococcal vaccine in army recruits in Finland (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53370

8 April 2022

0 references

1 reference

meningococcal vaccine

1 reference

2

H. Käyhty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53370

8 April 2022

author name string

P. H. Mäkelä

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53370

8 April 2022

P. Weckström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53370

8 April 2022

A. Sivonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53370

8 April 2022

O. V. Renkonen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53370

8 April 2022

language of work or name

English

0 references

publication date

1 November 1975

1 reference

11 September 2017

8 November 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=53370

full work available at URL

8 April 2022

https://api.elsevier.com/content/article/PII:S014067367592125X?httpAccept=text/xml

1 reference

10.1016/S0140-6736(75)92125-X

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)92125-X

https://api.elsevier.com/content/article/PII:S014067367592125X?httpAccept=text/plain

8 April 2022

1 reference

10.1016/S0140-6736(75)92125-X

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)92125-X

8 April 2022

1 reference

11 September 2017

volume

2

1 reference

11 September 2017

issue

7941

1 reference

11 September 2017

page(s)

883-886

1 reference

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

Serologic studies of meningococcal infection and polysaccharide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

Identification of an Epidemic Strain of Group C Neisseria meningitidis by Bactericidal Serotyping

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

Immunoprophylaxis of meningococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

The meningococcal carrier-rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992125-X

7 January 2021

10.1016/S0140-6736(75)92125-X

Identifiers

DOI

1 reference

11 September 2017

1 reference